nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2B6—Sorafenib—liver cancer	0.136	0.209	CbGbCtD
Nevirapine—CYP3A5—Sorafenib—liver cancer	0.107	0.165	CbGbCtD
Nevirapine—CYP2B6—Doxorubicin—liver cancer	0.0824	0.127	CbGbCtD
Nevirapine—CYP1A2—Sorafenib—liver cancer	0.0797	0.123	CbGbCtD
Nevirapine—CYP2C9—Sorafenib—liver cancer	0.0718	0.111	CbGbCtD
Nevirapine—CYP2D6—Sorafenib—liver cancer	0.0656	0.101	CbGbCtD
Nevirapine—CYP3A4—Sorafenib—liver cancer	0.0417	0.0643	CbGbCtD
Nevirapine—CYP2D6—Doxorubicin—liver cancer	0.0398	0.0613	CbGbCtD
Nevirapine—CYP3A4—Doxorubicin—liver cancer	0.0253	0.039	CbGbCtD
Nevirapine—Rhabdomyolysis—Sorafenib—liver cancer	0.00336	0.0186	CcSEcCtD
Nevirapine—Bone disorder—Sorafenib—liver cancer	0.0033	0.0183	CcSEcCtD
Nevirapine—Drug interaction—Sorafenib—liver cancer	0.00321	0.0178	CcSEcCtD
Nevirapine—Blood pressure increased—Sorafenib—liver cancer	0.00298	0.0165	CcSEcCtD
Nevirapine—Rash papular—Epirubicin—liver cancer	0.00295	0.0164	CcSEcCtD
Nevirapine—Skin exfoliation—Sorafenib—liver cancer	0.00284	0.0157	CcSEcCtD
Nevirapine—Bullous eruption—Epirubicin—liver cancer	0.00278	0.0154	CcSEcCtD
Nevirapine—Rash papular—Doxorubicin—liver cancer	0.00273	0.0151	CcSEcCtD
Nevirapine—Opportunistic infection—Epirubicin—liver cancer	0.00273	0.0151	CcSEcCtD
Nevirapine—Mouth ulceration—Sorafenib—liver cancer	0.00269	0.0149	CcSEcCtD
Nevirapine—Bullous eruption—Doxorubicin—liver cancer	0.00258	0.0143	CcSEcCtD
Nevirapine—Erythema nodosum—Epirubicin—liver cancer	0.00254	0.0141	CcSEcCtD
Nevirapine—Opportunistic infection—Doxorubicin—liver cancer	0.00253	0.014	CcSEcCtD
Nevirapine—Hepatic failure—Sorafenib—liver cancer	0.0024	0.0133	CcSEcCtD
Nevirapine—Ulcerative stomatitis—Epirubicin—liver cancer	0.00238	0.0132	CcSEcCtD
Nevirapine—Erythema nodosum—Doxorubicin—liver cancer	0.00235	0.013	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Sorafenib—liver cancer	0.00229	0.0127	CcSEcCtD
Nevirapine—Ulcerative stomatitis—Doxorubicin—liver cancer	0.00221	0.0122	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00195	0.0108	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00195	0.0108	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00191	0.0106	CcSEcCtD
Nevirapine—Pancreatitis—Sorafenib—liver cancer	0.00183	0.0101	CcSEcCtD
Nevirapine—Transaminases increased—Epirubicin—liver cancer	0.00181	0.01	CcSEcCtD
Nevirapine—Neutropenia—Sorafenib—liver cancer	0.00175	0.00968	CcSEcCtD
Nevirapine—Transaminases increased—Doxorubicin—liver cancer	0.00167	0.00927	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00165	0.00915	CcSEcCtD
Nevirapine—Renal failure—Sorafenib—liver cancer	0.00164	0.00907	CcSEcCtD
Nevirapine—Neuropathy peripheral—Sorafenib—liver cancer	0.00163	0.00904	CcSEcCtD
Nevirapine—Jaundice—Sorafenib—liver cancer	0.00162	0.00899	CcSEcCtD
Nevirapine—Hepatobiliary disease—Sorafenib—liver cancer	0.00158	0.00873	CcSEcCtD
Nevirapine—Blister—Epirubicin—liver cancer	0.00153	0.00846	CcSEcCtD
Nevirapine—Connective tissue disorder—Sorafenib—liver cancer	0.00147	0.00814	CcSEcCtD
Nevirapine—Rash erythematous—Epirubicin—liver cancer	0.00144	0.00796	CcSEcCtD
Nevirapine—Erythema multiforme—Sorafenib—liver cancer	0.00141	0.00783	CcSEcCtD
Nevirapine—Blister—Doxorubicin—liver cancer	0.00141	0.00782	CcSEcCtD
Nevirapine—Necrosis—Epirubicin—liver cancer	0.0014	0.00777	CcSEcCtD
Nevirapine—Immune system disorder—Sorafenib—liver cancer	0.00135	0.00748	CcSEcCtD
Nevirapine—Rash erythematous—Doxorubicin—liver cancer	0.00133	0.00736	CcSEcCtD
Nevirapine—Liver injury—Epirubicin—liver cancer	0.00131	0.00724	CcSEcCtD
Nevirapine—Erythema—Sorafenib—liver cancer	0.0013	0.00721	CcSEcCtD
Nevirapine—Necrosis—Doxorubicin—liver cancer	0.0013	0.00719	CcSEcCtD
Nevirapine—Bone disorder—Epirubicin—liver cancer	0.00122	0.00675	CcSEcCtD
Nevirapine—Liver injury—Doxorubicin—liver cancer	0.00121	0.0067	CcSEcCtD
Nevirapine—Anaemia—Sorafenib—liver cancer	0.0012	0.00666	CcSEcCtD
Nevirapine—Angioedema—Sorafenib—liver cancer	0.00119	0.00659	CcSEcCtD
Nevirapine—Ulcer—Epirubicin—liver cancer	0.00116	0.00644	CcSEcCtD
Nevirapine—Inflammation—Epirubicin—liver cancer	0.00113	0.00628	CcSEcCtD
Nevirapine—Bone disorder—Doxorubicin—liver cancer	0.00113	0.00624	CcSEcCtD
Nevirapine—Myalgia—Sorafenib—liver cancer	0.00111	0.00614	CcSEcCtD
Nevirapine—Arthralgia—Sorafenib—liver cancer	0.00111	0.00614	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0011	0.0061	CcSEcCtD
Nevirapine—Hepatocellular injury—Epirubicin—liver cancer	0.0011	0.0061	CcSEcCtD
Nevirapine—Ulcer—Doxorubicin—liver cancer	0.00108	0.00596	CcSEcCtD
Nevirapine—Anaphylactic shock—Sorafenib—liver cancer	0.00106	0.00588	CcSEcCtD
Nevirapine—Skin exfoliation—Epirubicin—liver cancer	0.00105	0.00582	CcSEcCtD
Nevirapine—Inflammation—Doxorubicin—liver cancer	0.00105	0.00581	CcSEcCtD
Nevirapine—Nervous system disorder—Sorafenib—liver cancer	0.00104	0.00577	CcSEcCtD
Nevirapine—Thrombocytopenia—Sorafenib—liver cancer	0.00104	0.00576	CcSEcCtD
Nevirapine—Skin disorder—Sorafenib—liver cancer	0.00103	0.00572	CcSEcCtD
Nevirapine—Hepatocellular injury—Doxorubicin—liver cancer	0.00102	0.00564	CcSEcCtD
Nevirapine—Anorexia—Sorafenib—liver cancer	0.00101	0.00561	CcSEcCtD
Nevirapine—Rash maculo-papular—Epirubicin—liver cancer	0.001	0.00554	CcSEcCtD
Nevirapine—Mouth ulceration—Epirubicin—liver cancer	0.000995	0.00551	CcSEcCtD
Nevirapine—Skin exfoliation—Doxorubicin—liver cancer	0.000972	0.00538	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000968	0.00536	CcSEcCtD
Nevirapine—Lymphadenopathy—Epirubicin—liver cancer	0.000936	0.00519	CcSEcCtD
Nevirapine—Rash maculo-papular—Doxorubicin—liver cancer	0.000925	0.00513	CcSEcCtD
Nevirapine—Decreased appetite—Sorafenib—liver cancer	0.000923	0.00512	CcSEcCtD
Nevirapine—Mouth ulceration—Doxorubicin—liver cancer	0.00092	0.0051	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000917	0.00508	CcSEcCtD
Nevirapine—Fatigue—Sorafenib—liver cancer	0.000916	0.00507	CcSEcCtD
Nevirapine—Pain—Sorafenib—liver cancer	0.000908	0.00503	CcSEcCtD
Nevirapine—Hepatic failure—Epirubicin—liver cancer	0.000889	0.00492	CcSEcCtD
Nevirapine—Gastrointestinal pain—Sorafenib—liver cancer	0.000869	0.00481	CcSEcCtD
Nevirapine—Lymphadenopathy—Doxorubicin—liver cancer	0.000866	0.0048	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000846	0.00469	CcSEcCtD
Nevirapine—Urticaria—Sorafenib—liver cancer	0.000844	0.00467	CcSEcCtD
Nevirapine—Abdominal pain—Sorafenib—liver cancer	0.00084	0.00465	CcSEcCtD
Nevirapine—Body temperature increased—Sorafenib—liver cancer	0.00084	0.00465	CcSEcCtD
Nevirapine—Dermatitis bullous—Epirubicin—liver cancer	0.000836	0.00463	CcSEcCtD
Nevirapine—Hepatic failure—Doxorubicin—liver cancer	0.000822	0.00456	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000783	0.00434	CcSEcCtD
Nevirapine—Hypersensitivity—Sorafenib—liver cancer	0.000783	0.00434	CcSEcCtD
Nevirapine—Dermatitis bullous—Doxorubicin—liver cancer	0.000773	0.00428	CcSEcCtD
Nevirapine—Face oedema—Epirubicin—liver cancer	0.000771	0.00427	CcSEcCtD
Nevirapine—Asthenia—Sorafenib—liver cancer	0.000762	0.00422	CcSEcCtD
Nevirapine—Pruritus—Sorafenib—liver cancer	0.000752	0.00416	CcSEcCtD
Nevirapine—Liver function test abnormal—Epirubicin—liver cancer	0.000737	0.00409	CcSEcCtD
Nevirapine—Diarrhoea—Sorafenib—liver cancer	0.000727	0.00403	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000719	0.00398	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000719	0.00398	CcSEcCtD
Nevirapine—Face oedema—Doxorubicin—liver cancer	0.000713	0.00395	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000704	0.0039	CcSEcCtD
Nevirapine—Eosinophilia—Epirubicin—liver cancer	0.000683	0.00379	CcSEcCtD
Nevirapine—Liver function test abnormal—Doxorubicin—liver cancer	0.000682	0.00378	CcSEcCtD
Nevirapine—Pancreatitis—Epirubicin—liver cancer	0.000677	0.00375	CcSEcCtD
Nevirapine—Vomiting—Sorafenib—liver cancer	0.000675	0.00374	CcSEcCtD
Nevirapine—Rash—Sorafenib—liver cancer	0.00067	0.00371	CcSEcCtD
Nevirapine—Dermatitis—Sorafenib—liver cancer	0.000669	0.00371	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000665	0.00369	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000665	0.00369	CcSEcCtD
Nevirapine—Headache—Sorafenib—liver cancer	0.000665	0.00369	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000652	0.00361	CcSEcCtD
Nevirapine—Neutropenia—Epirubicin—liver cancer	0.000646	0.00358	CcSEcCtD
Nevirapine—Eosinophilia—Doxorubicin—liver cancer	0.000632	0.0035	CcSEcCtD
Nevirapine—Nausea—Sorafenib—liver cancer	0.000631	0.0035	CcSEcCtD
Nevirapine—Pancreatitis—Doxorubicin—liver cancer	0.000626	0.00347	CcSEcCtD
Nevirapine—Hyperglycaemia—Epirubicin—liver cancer	0.000623	0.00345	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00061	0.00338	CcSEcCtD
Nevirapine—Renal failure—Epirubicin—liver cancer	0.000605	0.00335	CcSEcCtD
Nevirapine—Neuropathy peripheral—Epirubicin—liver cancer	0.000603	0.00334	CcSEcCtD
Nevirapine—Jaundice—Epirubicin—liver cancer	0.0006	0.00332	CcSEcCtD
Nevirapine—Conjunctivitis—Epirubicin—liver cancer	0.000598	0.00331	CcSEcCtD
Nevirapine—Neutropenia—Doxorubicin—liver cancer	0.000597	0.00331	CcSEcCtD
Nevirapine—Hepatobiliary disease—Epirubicin—liver cancer	0.000582	0.00322	CcSEcCtD
Nevirapine—Hyperglycaemia—Doxorubicin—liver cancer	0.000576	0.00319	CcSEcCtD
Nevirapine—Agranulocytosis—Epirubicin—liver cancer	0.000574	0.00318	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000565	0.00313	CcSEcCtD
Nevirapine—Renal failure—Doxorubicin—liver cancer	0.00056	0.0031	CcSEcCtD
Nevirapine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000558	0.00309	CcSEcCtD
Nevirapine—Jaundice—Doxorubicin—liver cancer	0.000555	0.00308	CcSEcCtD
Nevirapine—Conjunctivitis—Doxorubicin—liver cancer	0.000554	0.00307	CcSEcCtD
Nevirapine—Hepatitis—Epirubicin—liver cancer	0.000553	0.00306	CcSEcCtD
Nevirapine—Connective tissue disorder—Epirubicin—liver cancer	0.000543	0.00301	CcSEcCtD
Nevirapine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000539	0.00298	CcSEcCtD
Nevirapine—Agranulocytosis—Doxorubicin—liver cancer	0.000531	0.00294	CcSEcCtD
Nevirapine—Erythema multiforme—Epirubicin—liver cancer	0.000522	0.00289	CcSEcCtD
Nevirapine—Hepatitis—Doxorubicin—liver cancer	0.000511	0.00283	CcSEcCtD
Nevirapine—Connective tissue disorder—Doxorubicin—liver cancer	0.000502	0.00278	CcSEcCtD
Nevirapine—Immune system disorder—Epirubicin—liver cancer	0.000499	0.00276	CcSEcCtD
Nevirapine—Erythema multiforme—Doxorubicin—liver cancer	0.000483	0.00268	CcSEcCtD
Nevirapine—Erythema—Epirubicin—liver cancer	0.000481	0.00266	CcSEcCtD
Nevirapine—Immune system disorder—Doxorubicin—liver cancer	0.000462	0.00256	CcSEcCtD
Nevirapine—Ill-defined disorder—Epirubicin—liver cancer	0.000446	0.00247	CcSEcCtD
Nevirapine—Erythema—Doxorubicin—liver cancer	0.000445	0.00247	CcSEcCtD
Nevirapine—Anaemia—Epirubicin—liver cancer	0.000445	0.00246	CcSEcCtD
Nevirapine—Malaise—Epirubicin—liver cancer	0.000434	0.0024	CcSEcCtD
Nevirapine—Ill-defined disorder—Doxorubicin—liver cancer	0.000413	0.00229	CcSEcCtD
Nevirapine—Anaemia—Doxorubicin—liver cancer	0.000411	0.00228	CcSEcCtD
Nevirapine—Arthralgia—Epirubicin—liver cancer	0.00041	0.00227	CcSEcCtD
Nevirapine—Myalgia—Epirubicin—liver cancer	0.00041	0.00227	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000407	0.00225	CcSEcCtD
Nevirapine—Discomfort—Epirubicin—liver cancer	0.000405	0.00224	CcSEcCtD
Nevirapine—Malaise—Doxorubicin—liver cancer	0.000401	0.00222	CcSEcCtD
Nevirapine—Oedema—Epirubicin—liver cancer	0.000393	0.00217	CcSEcCtD
Nevirapine—Anaphylactic shock—Epirubicin—liver cancer	0.000393	0.00217	CcSEcCtD
Nevirapine—Nervous system disorder—Epirubicin—liver cancer	0.000385	0.00213	CcSEcCtD
Nevirapine—Thrombocytopenia—Epirubicin—liver cancer	0.000384	0.00213	CcSEcCtD
Nevirapine—Skin disorder—Epirubicin—liver cancer	0.000381	0.00211	CcSEcCtD
Nevirapine—Arthralgia—Doxorubicin—liver cancer	0.000379	0.0021	CcSEcCtD
Nevirapine—Myalgia—Doxorubicin—liver cancer	0.000379	0.0021	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000376	0.00208	CcSEcCtD
Nevirapine—Discomfort—Doxorubicin—liver cancer	0.000374	0.00207	CcSEcCtD
Nevirapine—Anorexia—Epirubicin—liver cancer	0.000374	0.00207	CcSEcCtD
Nevirapine—Anaphylactic shock—Doxorubicin—liver cancer	0.000363	0.00201	CcSEcCtD
Nevirapine—Oedema—Doxorubicin—liver cancer	0.000363	0.00201	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000358	0.00198	CcSEcCtD
Nevirapine—Nervous system disorder—Doxorubicin—liver cancer	0.000356	0.00197	CcSEcCtD
Nevirapine—Thrombocytopenia—Doxorubicin—liver cancer	0.000356	0.00197	CcSEcCtD
Nevirapine—Skin disorder—Doxorubicin—liver cancer	0.000353	0.00195	CcSEcCtD
Nevirapine—Paraesthesia—Epirubicin—liver cancer	0.000352	0.00195	CcSEcCtD
Nevirapine—Somnolence—Epirubicin—liver cancer	0.000349	0.00193	CcSEcCtD
Nevirapine—Anorexia—Doxorubicin—liver cancer	0.000346	0.00192	CcSEcCtD
Nevirapine—Decreased appetite—Epirubicin—liver cancer	0.000341	0.00189	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000339	0.00188	CcSEcCtD
Nevirapine—Fatigue—Epirubicin—liver cancer	0.000338	0.00187	CcSEcCtD
Nevirapine—Pain—Epirubicin—liver cancer	0.000336	0.00186	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000331	0.00183	CcSEcCtD
Nevirapine—Paraesthesia—Doxorubicin—liver cancer	0.000326	0.00181	CcSEcCtD
Nevirapine—Feeling abnormal—Epirubicin—liver cancer	0.000323	0.00179	CcSEcCtD
Nevirapine—Somnolence—Doxorubicin—liver cancer	0.000323	0.00179	CcSEcCtD
Nevirapine—Gastrointestinal pain—Epirubicin—liver cancer	0.000321	0.00178	CcSEcCtD
Nevirapine—Decreased appetite—Doxorubicin—liver cancer	0.000316	0.00175	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000314	0.00174	CcSEcCtD
Nevirapine—Fatigue—Doxorubicin—liver cancer	0.000313	0.00173	CcSEcCtD
Nevirapine—Urticaria—Epirubicin—liver cancer	0.000312	0.00173	CcSEcCtD
Nevirapine—Pain—Doxorubicin—liver cancer	0.000311	0.00172	CcSEcCtD
Nevirapine—Body temperature increased—Epirubicin—liver cancer	0.00031	0.00172	CcSEcCtD
Nevirapine—Abdominal pain—Epirubicin—liver cancer	0.00031	0.00172	CcSEcCtD
Nevirapine—Feeling abnormal—Doxorubicin—liver cancer	0.000299	0.00166	CcSEcCtD
Nevirapine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000297	0.00165	CcSEcCtD
Nevirapine—Hypersensitivity—Epirubicin—liver cancer	0.000289	0.0016	CcSEcCtD
Nevirapine—Urticaria—Doxorubicin—liver cancer	0.000289	0.0016	CcSEcCtD
Nevirapine—Abdominal pain—Doxorubicin—liver cancer	0.000287	0.00159	CcSEcCtD
Nevirapine—Body temperature increased—Doxorubicin—liver cancer	0.000287	0.00159	CcSEcCtD
Nevirapine—Asthenia—Epirubicin—liver cancer	0.000282	0.00156	CcSEcCtD
Nevirapine—Pruritus—Epirubicin—liver cancer	0.000278	0.00154	CcSEcCtD
Nevirapine—Diarrhoea—Epirubicin—liver cancer	0.000269	0.00149	CcSEcCtD
Nevirapine—Hypersensitivity—Doxorubicin—liver cancer	0.000268	0.00148	CcSEcCtD
Nevirapine—Asthenia—Doxorubicin—liver cancer	0.000261	0.00144	CcSEcCtD
Nevirapine—Pruritus—Doxorubicin—liver cancer	0.000257	0.00142	CcSEcCtD
Nevirapine—Vomiting—Epirubicin—liver cancer	0.00025	0.00138	CcSEcCtD
Nevirapine—Diarrhoea—Doxorubicin—liver cancer	0.000249	0.00138	CcSEcCtD
Nevirapine—Rash—Epirubicin—liver cancer	0.000248	0.00137	CcSEcCtD
Nevirapine—Dermatitis—Epirubicin—liver cancer	0.000247	0.00137	CcSEcCtD
Nevirapine—Headache—Epirubicin—liver cancer	0.000246	0.00136	CcSEcCtD
Nevirapine—Nausea—Epirubicin—liver cancer	0.000233	0.00129	CcSEcCtD
Nevirapine—Vomiting—Doxorubicin—liver cancer	0.000231	0.00128	CcSEcCtD
Nevirapine—Rash—Doxorubicin—liver cancer	0.000229	0.00127	CcSEcCtD
Nevirapine—Dermatitis—Doxorubicin—liver cancer	0.000229	0.00127	CcSEcCtD
Nevirapine—Headache—Doxorubicin—liver cancer	0.000228	0.00126	CcSEcCtD
Nevirapine—Nausea—Doxorubicin—liver cancer	0.000216	0.0012	CcSEcCtD
Nevirapine—CYP2C9—Metabolism—UGDH—liver cancer	7.35e-05	0.000432	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	7.34e-05	0.000431	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—EPT1—liver cancer	6.97e-05	0.000409	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTA4—liver cancer	6.94e-05	0.000408	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—EPT1—liver cancer	6.91e-05	0.000406	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—GSTM1—liver cancer	6.84e-05	0.000402	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTA2—liver cancer	6.77e-05	0.000398	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	6.74e-05	0.000396	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—TAT—liver cancer	6.61e-05	0.000388	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—TAT—liver cancer	6.55e-05	0.000385	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTA1—liver cancer	6.53e-05	0.000384	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	6.48e-05	0.000381	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CPT1B—liver cancer	6.46e-05	0.00038	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GLUL—liver cancer	6.46e-05	0.00038	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NAT2—liver cancer	6.46e-05	0.000379	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.44e-05	0.000378	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	6.39e-05	0.000375	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CPT1B—liver cancer	6.32e-05	0.000371	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GLUL—liver cancer	6.32e-05	0.000371	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.3e-05	0.00037	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—UGDH—liver cancer	6.28e-05	0.000369	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NR1H4—liver cancer	6.23e-05	0.000366	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALDOB—liver cancer	6.19e-05	0.000364	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTA3—liver cancer	6.13e-05	0.00036	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NR1H4—liver cancer	6.09e-05	0.000358	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTA3—liver cancer	5.99e-05	0.000352	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—EPT1—liver cancer	5.9e-05	0.000347	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CRABP1—liver cancer	5.9e-05	0.000347	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTA4—liver cancer	5.6e-05	0.000329	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—TAT—liver cancer	5.6e-05	0.000329	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.5e-05	0.000323	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTA4—liver cancer	5.48e-05	0.000322	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTA2—liver cancer	5.46e-05	0.000321	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTA2—liver cancer	5.34e-05	0.000313	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTA1—liver cancer	5.27e-05	0.000309	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NAT2—liver cancer	5.21e-05	0.000306	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—HPGDS—liver cancer	5.16e-05	0.000303	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTA1—liver cancer	5.15e-05	0.000302	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NAT2—liver cancer	5.09e-05	0.000299	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALDOB—liver cancer	4.99e-05	0.000293	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALDOB—liver cancer	4.88e-05	0.000287	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—UGDH—liver cancer	4.85e-05	0.000285	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.82e-05	0.000283	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CRABP1—liver cancer	4.76e-05	0.00028	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CRABP1—liver cancer	4.66e-05	0.000274	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PSMD10—liver cancer	4.6e-05	0.00027	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PSMA4—liver cancer	4.6e-05	0.00027	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—EPT1—liver cancer	4.56e-05	0.000268	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GLUL—liver cancer	4.49e-05	0.000264	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CPT1B—liver cancer	4.49e-05	0.000264	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GOT2—liver cancer	4.47e-05	0.000263	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CPT1B—liver cancer	4.45e-05	0.000262	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GLUL—liver cancer	4.45e-05	0.000262	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NR1H4—liver cancer	4.33e-05	0.000254	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—TAT—liver cancer	4.32e-05	0.000254	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NR1H4—liver cancer	4.29e-05	0.000252	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTA3—liver cancer	4.26e-05	0.00025	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTA3—liver cancer	4.22e-05	0.000248	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP2E1—liver cancer	4.21e-05	0.000247	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HPGDS—liver cancer	4.16e-05	0.000245	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.12e-05	0.000242	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HPGDS—liver cancer	4.07e-05	0.000239	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYCS—liver cancer	3.94e-05	0.000231	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTA4—liver cancer	3.89e-05	0.000229	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GGT1—liver cancer	3.86e-05	0.000227	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GOT1—liver cancer	3.86e-05	0.000227	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTA4—liver cancer	3.86e-05	0.000227	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CPT1B—liver cancer	3.8e-05	0.000223	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GLUL—liver cancer	3.8e-05	0.000223	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTA2—liver cancer	3.79e-05	0.000223	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.77e-05	0.000222	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTA2—liver cancer	3.76e-05	0.000221	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PSMD10—liver cancer	3.71e-05	0.000218	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PSMA4—liver cancer	3.71e-05	0.000218	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NR1H4—liver cancer	3.67e-05	0.000216	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTA1—liver cancer	3.66e-05	0.000215	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTA1—liver cancer	3.63e-05	0.000213	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PSMA4—liver cancer	3.63e-05	0.000213	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PSMD10—liver cancer	3.63e-05	0.000213	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NAT2—liver cancer	3.62e-05	0.000213	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GOT2—liver cancer	3.61e-05	0.000212	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTA3—liver cancer	3.61e-05	0.000212	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NAT2—liver cancer	3.59e-05	0.000211	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GOT2—liver cancer	3.53e-05	0.000207	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALDOB—liver cancer	3.47e-05	0.000204	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTP1—liver cancer	3.47e-05	0.000204	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.45e-05	0.000203	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALDOB—liver cancer	3.44e-05	0.000202	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—HMOX1—liver cancer	3.42e-05	0.000201	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP2E1—liver cancer	3.39e-05	0.000199	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP2E1—liver cancer	3.32e-05	0.000195	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CRABP1—liver cancer	3.31e-05	0.000194	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTA4—liver cancer	3.3e-05	0.000194	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CRABP1—liver cancer	3.28e-05	0.000193	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.22e-05	0.000189	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTA2—liver cancer	3.21e-05	0.000189	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTM1—liver cancer	3.19e-05	0.000187	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYCS—liver cancer	3.18e-05	0.000187	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GOT1—liver cancer	3.12e-05	0.000183	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GGT1—liver cancer	3.12e-05	0.000183	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYCS—liver cancer	3.1e-05	0.000182	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTA1—liver cancer	3.1e-05	0.000182	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NAT2—liver cancer	3.07e-05	0.00018	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GGT1—liver cancer	3.05e-05	0.000179	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GOT1—liver cancer	3.05e-05	0.000179	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP1A1—liver cancer	3.02e-05	0.000178	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.96e-05	0.000174	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.95e-05	0.000173	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALDOB—liver cancer	2.94e-05	0.000173	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CPT1B—liver cancer	2.94e-05	0.000172	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GLUL—liver cancer	2.94e-05	0.000172	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HPGDS—liver cancer	2.89e-05	0.00017	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HPGDS—liver cancer	2.87e-05	0.000169	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.85e-05	0.000168	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NR1H4—liver cancer	2.83e-05	0.000166	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—MTHFR—liver cancer	2.82e-05	0.000166	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CRABP1—liver cancer	2.8e-05	0.000165	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTP1—liver cancer	2.8e-05	0.000164	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA3—liver cancer	2.78e-05	0.000164	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARA—liver cancer	2.76e-05	0.000162	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HMOX1—liver cancer	2.76e-05	0.000162	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTP1—liver cancer	2.74e-05	0.000161	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HMOX1—liver cancer	2.7e-05	0.000159	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.6e-05	0.000153	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PSMD10—liver cancer	2.58e-05	0.000152	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PSMA4—liver cancer	2.58e-05	0.000152	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTM1—liver cancer	2.57e-05	0.000151	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.56e-05	0.000151	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PSMD10—liver cancer	2.56e-05	0.00015	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PSMA4—liver cancer	2.56e-05	0.00015	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA4—liver cancer	2.55e-05	0.00015	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.53e-05	0.000148	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTM1—liver cancer	2.51e-05	0.000148	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GOT2—liver cancer	2.51e-05	0.000147	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GOT2—liver cancer	2.49e-05	0.000146	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA2—liver cancer	2.48e-05	0.000146	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HPGDS—liver cancer	2.45e-05	0.000144	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP1A1—liver cancer	2.44e-05	0.000143	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.44e-05	0.000143	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA1—liver cancer	2.39e-05	0.000141	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP1A1—liver cancer	2.38e-05	0.00014	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CG—liver cancer	2.37e-05	0.000139	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NAT2—liver cancer	2.37e-05	0.000139	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP2E1—liver cancer	2.36e-05	0.000139	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2E1—liver cancer	2.34e-05	0.000137	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARG—liver cancer	2.28e-05	0.000134	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MTHFR—liver cancer	2.27e-05	0.000134	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALDOB—liver cancer	2.27e-05	0.000133	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.26e-05	0.000133	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARA—liver cancer	2.23e-05	0.000131	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MTHFR—liver cancer	2.22e-05	0.000131	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.22e-05	0.00013	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYCS—liver cancer	2.21e-05	0.00013	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.19e-05	0.000129	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYCS—liver cancer	2.19e-05	0.000129	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PSMA4—liver cancer	2.19e-05	0.000128	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PSMD10—liver cancer	2.19e-05	0.000128	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARA—liver cancer	2.18e-05	0.000128	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GOT1—liver cancer	2.17e-05	0.000127	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GGT1—liver cancer	2.17e-05	0.000127	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CRABP1—liver cancer	2.16e-05	0.000127	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GGT1—liver cancer	2.15e-05	0.000126	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GOT1—liver cancer	2.15e-05	0.000126	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GOT2—liver cancer	2.13e-05	0.000125	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CD—liver cancer	2.08e-05	0.000122	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—liver cancer	2.05e-05	0.000121	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2E1—liver cancer	2e-05	0.000117	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTP1—liver cancer	1.95e-05	0.000114	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.94e-05	0.000114	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTP1—liver cancer	1.93e-05	0.000113	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMOX1—liver cancer	1.92e-05	0.000113	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CG—liver cancer	1.91e-05	0.000112	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMOX1—liver cancer	1.9e-05	0.000112	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HPGDS—liver cancer	1.89e-05	0.000111	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYCS—liver cancer	1.87e-05	0.00011	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CG—liver cancer	1.87e-05	0.00011	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARG—liver cancer	1.84e-05	0.000108	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GGT1—liver cancer	1.83e-05	0.000108	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GOT1—liver cancer	1.83e-05	0.000108	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CB—liver cancer	1.81e-05	0.000107	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARG—liver cancer	1.8e-05	0.000106	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTM1—liver cancer	1.79e-05	0.000105	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTM1—liver cancer	1.77e-05	0.000104	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.69e-05	9.96e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PSMD10—liver cancer	1.69e-05	9.91e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PSMA4—liver cancer	1.69e-05	9.91e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP1A1—liver cancer	1.68e-05	9.87e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CD—liver cancer	1.68e-05	9.86e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—liver cancer	1.66e-05	9.74e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTP1—liver cancer	1.65e-05	9.68e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CD—liver cancer	1.64e-05	9.64e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GOT2—liver cancer	1.64e-05	9.64e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMOX1—liver cancer	1.63e-05	9.55e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—liver cancer	1.62e-05	9.52e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTHFR—liver cancer	1.58e-05	9.28e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTHFR—liver cancer	1.57e-05	9.2e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARA—liver cancer	1.55e-05	9.11e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.54e-05	9.06e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARA—liver cancer	1.54e-05	9.03e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTM1—liver cancer	1.51e-05	8.9e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CB—liver cancer	1.46e-05	8.6e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYCS—liver cancer	1.44e-05	8.48e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP1A1—liver cancer	1.44e-05	8.43e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CB—liver cancer	1.43e-05	8.4e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GGT1—liver cancer	1.42e-05	8.32e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GOT1—liver cancer	1.42e-05	8.32e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.38e-05	8.11e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTHFR—liver cancer	1.34e-05	7.86e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.33e-05	7.8e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CG—liver cancer	1.32e-05	7.73e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARA—liver cancer	1.31e-05	7.71e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARG—liver cancer	1.28e-05	7.53e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTP1—liver cancer	1.27e-05	7.47e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARG—liver cancer	1.27e-05	7.46e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMOX1—liver cancer	1.25e-05	7.37e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.18e-05	6.93e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM1—liver cancer	1.17e-05	6.87e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.17e-05	6.86e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CD—liver cancer	1.16e-05	6.8e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—liver cancer	1.15e-05	6.77e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—liver cancer	1.14e-05	6.71e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CG—liver cancer	1.12e-05	6.61e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.11e-05	6.51e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—liver cancer	1.11e-05	6.5e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARG—liver cancer	1.09e-05	6.38e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTHFR—liver cancer	1.03e-05	6.07e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.02e-05	5.98e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARA—liver cancer	1.01e-05	5.95e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CB—liver cancer	1.01e-05	5.92e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CD—liver cancer	9.89e-06	5.81e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—liver cancer	9.76e-06	5.73e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—liver cancer	9.03e-06	5.31e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—liver cancer	8.92e-06	5.24e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—liver cancer	8.72e-06	5.12e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CG—liver cancer	8.68e-06	5.1e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CB—liver cancer	8.62e-06	5.06e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARG—liver cancer	8.38e-06	4.92e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CD—liver cancer	7.63e-06	4.48e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—liver cancer	7.53e-06	4.42e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—liver cancer	7.29e-06	4.28e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—liver cancer	7.12e-06	4.19e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CB—liver cancer	6.65e-06	3.91e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—liver cancer	6.2e-06	3.64e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—liver cancer	6.15e-06	3.61e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—liver cancer	5.25e-06	3.09e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—liver cancer	5.07e-06	2.98e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—liver cancer	5.02e-06	2.95e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—liver cancer	4.29e-06	2.52e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—liver cancer	4.05e-06	2.38e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—liver cancer	3.31e-06	1.95e-05	CbGpPWpGaD
